Español
It is a line of in vitro diagnostic products for the detection and genotyping of different types of Human Papillomavirus (HPV).
It uses multiplex PCR and subsequent visualization in low density arrays, using CLART® technology.
CLART® HPV Line products are capable of detecting both high and low risk Papilloma virus genotypes in a single assay. This classification is determined by the innate ability of viruses considered high risk to cause cervical cancer, as well as their involvement in other types of cancer (pharyngeal, anal…).
With CLART® HPV Line, it is also possible to detect multiple infections in a single sample, which facilitates the long-term follow-up of patients. The genotyping of the human papillomavirus makes it possible to follow up the infection in the patient, as well as to carry out epidemiological studies in those populations where vaccination has been implemented in girls.
CLART® HPV4
CLART® HPV4 offers full screening 35 genotypes: High Risk (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68A-68B), Probable High Risk (26, 53, 73, 82) and Low risk (6, 11, 40, 42, 43, 44, 54, 61, 62, 71, 70, 72, 81, 83, 84, 85, 89).
CLART® HPV4s
CLART® HPV4s offers detection of High-Risk Genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68A-68B) plus the two most common low risk ones (6, 11).
CLART® HPV4sHR
CLART HPV4s offers the detection of High Risk Genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68A-68B).
CLART® HPV3
CLART HPV3 detects 49 genotypes including High Risk (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68), Low Risk (6, 11, 40, 42, 43, 44, 54, 61, 62, 70, 71, 72, 81, 83, 84, 85, 89), and indeterminate risk genotypes targeted for investigation (34, 64, 67, 69 74, 86, 87, 97, 101, 102, 103, 106, 150, 151).